Anti-inflammatory and ulcerogenic effects and pharmacokinetics of oxyphenbutazone in protein deficient rats.
D000818:Animals; D002351:Carrageenan / Q000009:adverse effects; D003876:Dermatitis, Atopic / Q000517:prevention & control*; D004044:Dietary Proteins / Q000008:administration & dosage; D007700:Kinetics; D008297:Male; D010113:Oxyphenbutazone / Q000378:metabolism / Q000633:toxicity*; D011488:Protein Deficiency / Q000378:metabolism*; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced*
D004044:Dietary Proteins; D002351:Carrageenan; D010113:Oxyphenbutazone